Definitely agree with you. MMJ sold its holding (not options) of Medipharm at an optimal time.
With legalization of edibles in Canada expected by the end of this year, we should see a considerable rebound in Harvest's share price.
In my opinion, it's a great time to buy in both MMJ and Harvest One given our considerable stake in the company, the buy-back, Embark's Share Price performance milestones along with dividend payout expected at the start of next year
MMJ Price at posting:
29.0¢ Sentiment: None Disclosure: Held
